Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Results from studies on neuropathic pain treatments presented at AAN meeting

May 14, 2001

Safety and efficacy of dopamine agonists in treatment of restless legs syndrome

May 14, 2001

Neurotrophic hydrazides emerge from R&D at Taisho

May 11, 2001

Modulators of PGE receptors with improved toxicity discovered at Merck Frosst

May 11, 2001

High-dose valaciclovir safe in MS patients treated for two years

May 11, 2001

Elan to evaluate MyoBloc for additional indications

May 11, 2001

Phase I results for oral interferon tau support efficacy trials in MS patients

May 11, 2001

Taurolidine merits further investigation as a neuroprotectant according to recent findings

May 11, 2001

Small molecule designed at Prescient NeuroPharma active in rat model of stroke

May 11, 2001

Preparation, binding and use of novel NMDA antagonists disclosed by Roche

May 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
BIO 2026: Alternatives to funding orphan drugs
BioWorld
At the BIO International Convention, nonprofit and for-profit companies discussed ways to fund orphan drug development, especially for ultra-rare diseases where...
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...